Correlation Between 064159QE9 and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 064159QE9 and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 064159QE9 and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BANK OF NOVA and Pfizer Inc, you can compare the effects of market volatilities on 064159QE9 and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 064159QE9 with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of 064159QE9 and Pfizer.

Diversification Opportunities for 064159QE9 and Pfizer

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between 064159QE9 and Pfizer is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding BANK OF NOVA and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and 064159QE9 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BANK OF NOVA are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of 064159QE9 i.e., 064159QE9 and Pfizer go up and down completely randomly.

Pair Corralation between 064159QE9 and Pfizer

Assuming the 90 days trading horizon BANK OF NOVA is expected to generate 0.53 times more return on investment than Pfizer. However, BANK OF NOVA is 1.9 times less risky than Pfizer. It trades about -0.01 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.04 per unit of risk. If you would invest  9,474  in BANK OF NOVA on September 1, 2024 and sell it today you would lose (96.00) from holding BANK OF NOVA or give up 1.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.21%
ValuesDaily Returns

BANK OF NOVA  vs.  Pfizer Inc

 Performance 
       Timeline  
BANK OF NOVA 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BANK OF NOVA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 064159QE9 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

064159QE9 and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 064159QE9 and Pfizer

The main advantage of trading using opposite 064159QE9 and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 064159QE9 position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind BANK OF NOVA and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance